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The connexin43 knockout (Cx43a1 KO) mouse dies at birth from outflow obstruction associated with infundibular pouches. To elucidate
the origin of the infundibular pouches, we used microarray analysis to investigate gene expression changes in the pouch tissue. We found
elevated expression of many genes encoding markers for vascular smooth muscle (VSM), endothelial cells, and fibroblasts, cell types that are
epicardially derived and essential for coronary vasculogenesis. This was accompanied by increased expression of VEGF and genes in the
TGFh and VEGF/Notch/Eph cell-signaling pathways known to regulate vasculogenesis/angiogenesis. Using immunohistochemistry and a
VSM lacZ reporter gene, we confirmed an abundance of ectopic VSM and endothelial cells in the infundibular pouch and in some regions of
the right ventricle forming secondary pouches. This was associated with distinct thinning of the compact myocardium. TUNEL labeling
showed increased apoptosis in the pouch tissue, in agreement with the finding of altered expression of many apoptotic genes. Defects in
vascular remodeling were indicated by a marked reduction in the branching complexity of the distal coronary arteries. In the near term KO
mouse, we also observed a profusion of large coronary vascular plexuses subepicardially. This was associated with elevated epicardial
expression of VEGF and abnormal epicardial cell morphology. Together, these observations indicate that dysregulated coronary
vasculogenesis plays a pivotal role in formation of the infundibular pouches and suggests an essential role for Cx43a1 gap junctions in
coronary vasculogenesis and vascular remodeling.
Published by Elsevier Inc.Keywords: Coronary vessels; Connexin43; Knockout; VEGF; Vascular smooth muscle; Endothelial cells; Heart developmentIntroduction
Gap junctions are membrane channels that serve as major
conduits for cell–cell communication by mediating the
intercellular passage of ions and small molecules (Bruzzone
et al., 1996). They have been suggested to play a role in
tissue homeostasis, in the regulation of cell proliferation and
growth, and in differentiation and development (Evans and
Martin, 2002; Lo and Gilula, 1979; Simon and Good-
enough, 1998). Gap junctions are comprised of hexameric
arrays of protein subunits encoded by the connexin multi-0012-1606/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.ydbio.2005.06.004
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E-mail address: LoC@nhlbi.nih.gov (C.W. Lo).gene family. In the mammalian heart, the connexin gene
Gja1 (referred to as Cx43a1) is abundantly expressed in the
working myocardium, where it plays an important role in
heart conduction by mediating electrical synchrony (Severs,
2000). In addition, Cx43a1 plays an essential role in heart
development (Reaume et al., 1995), as the Cx43a1 knock-
out (KO) mice die at birth from conotruncal heart
malformations. These malformations consist of pouches
positioned at the base of the pulmonary outflow tract, a
region known as the infundibulum. These pouches are
comprised of elaborate intraventricular trabeculations form-
ing lacunae and sinusoidal cavities and are thought to cause
pulmonary outflow obstruction, thereby resulting in neo-
natal lethality due to a failure to establish normal pulmonary
circulation (Reaume et al., 1995). In addition to the284 (2005) 479 – 498
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various coronary artery anomalies that include accessory
coronary artery insertions into the aorta, anomalous origin
of the coronary arteries, and tunneling of the coronary
arteries (Li et al., 2002).
These striking phenotypes suggested an important role
for Cx43a1 in outflow tract morphogenesis and coronary
artery deployment, but whether the pouch phenotype might
arise independently of the coronary anomalies was not
known. Our previous studies indicate that the cardiac
defects of the Cx43a1 KO mouse involve defects in cardiac
neural crest migration (Huang et al., 1998a). Cardiac neural
crest cells are known to play an essential role in outflow
tract tissue remodeling. They also play an important role in
regulating patterning of the coronary arteries but do not
contribute cells to the coronary arteries (Hood and
Rosenquist, 1992; Waldo et al., 1994, 1998). In the
Cx43a1 KO mouse, we observe a spectrum of coronary
artery insertion defects that are similar to those seen with
cardiac neural crest ablation (Li et al., 2002). Although
Cx43a1-deficient neural crest cells do migrate to the heart,
neural crest abundance is markedly reduced in the outflow
tract of the Cx43a1 KO mouse heart. Our studies suggest
that this is likely due to a reduction in the motility of
Cx43a1-deficient neural crest cells (Huang et al., 1998a).
Outflow obstruction also has been observed in transgenic
mice with neural crest-targeted up- or downregulation of
Cx43a1 function (Ewart et al., 1997; Huang et al., 1998b;
Sullivan et al., 1998). However, these transgenic mice do
not exhibit the infundibular pouch malformations seen in the
Cx43a1 KO mouse. This has led us to consider the
involvement of yet another migratory cell population
essential for coronary vasculogenesis, the proepicardial
cells. These cells, unlike the cardiac neural crest cells,
contribute directly to formation of the coronary arteries by
providing all of the vascular progenitors (Dettman et al.,
1998; Gittenberger-de Groot et al., 1998; Mikawa and
Gourdie, 1996; Munoz-Chapuli et al., 2002; Poelmann
et al., 1993).
Proepicardial cells originate from the septum trans-
versum and delaminate to form the outer mesothelial
covering of the heart known as the epicardium. Subse-
quently, cells from the epicardium undergo an epithelial–
mesenchymal cell transformation (EMT) to generate vas-
cular progenitors that differentiate into the vascular smooth
muscle (VSM), fibroblasts, and endothelial cells that
participate in coronary vasculogenesis in the heart (Dettman
et al., 1998; Gittenberger-de Groot et al., 1998; Mikawa and
Gourdie, 1996; Poelmann et al., 1993). Significantly,
coronary arteries do not form after experimental ablation
of the PEO or in KO mice with mutations that target the
proepicardial cells or epicardium (Dettman et al., 1998;
Gittenberger-de Groot et al., 2000; Kwee et al., 1995; Yang
et al., 1995). Interestingly, in chick embryos, conotruncal
pouches similar to those in the Cx43a1 KO mouse heart
were generated with the experimental perturbation ofproepicardial cell migration (Perez-Pomares et al., 2002).
The latter observations reinforce the notion that defects
involving the PEO may contribute to the pouch phenotype
in the Cx43a1 KO mouse. Consistent with this possibility,
we previously showed that Cx43a1-deficient proepicardial
cells have increased motility and increased cell proliferation
(Li et al., 2002). However, the precise contribution of the
proepicardial cells to the pouch vs. coronary artery
phenotypes in the Cx43a1 KO mouse remains unknown.
To investigate the possible etiology of the infundibular
pouch tissue, we pursued microarray experiments to charac-
terize gene expression changes in the E17.5 Cx43a1 KO
mouse heart. For these experiments, RNA was extracted
either from whole ventricles or ventricles that were micro-
dissected to separate the pouch tissue from the remaining
ventricular myocardium. For controls, RNA was obtained
from whole ventricles or comparable regions of the infun-
dibulum vs. remaining ventricular myocardium of the hearts
of wildtype littermates. RNA extracted from these micro-
dissected infundibular/pouch tissues, as well as whole
ventricles were used for microarray analysis. Striking
changes in gene expression profile were observed in the
microdissected pouch tissues. These gene expression changes
indicated an abnormal expansion of VSM, endothelial, and
myofibroblast cells in the infundibular pouches. The pouch
tissue also showed increased expression of VEGF, as well as
altered expression of genes from cell-signaling pathways
involved in vasculogenesis/angiogenesis. These findings
were apparent only in the microarray analyses carried out
with the pouch tissue, not whole ventricle RNA samples.
They suggest a central role for defects in coronary vasculo-
genesis/angiogenesis in the pouch phenotype of the Cx43a1
KO mouse heart. Immunohistochemistry and other studies
confirmed an abundance of ectopic VSM, endothelial, and
myofibroblast cells in the pouch tissues. In addition, we
observed a reduction in the branching complexity of the
coronary arteries, which indicated additional defects in
coronary vascular remodeling in the Cx43a1 KO mouse
heart. In the near term KO mouse, we also observed a
profusion of enlarged subepicardial coronary plexuses
associated with elevated VEGF expression in the epicardium.
Together, these findings indicate that dysregulated coronary
vasculogenesis/angiogenesis may underlie the pouch pheno-
type in the Cx43a1 KO mouse and suggest an essential role
for Cx43a1 gap junctions in coronary vasculogenesis and
angiogenesis.Materials and methods
Animal breeding
Cx43a1 KO mice (Reaume et al., 1995) in a C57BL6/J
strain background were used for all of the experiments,
except for the SM22a-lacZ analysis. To generate mice that
are double heterozygous for the Cx43a1 and SM22a/LacZ
D.L. Walker et al. / Developmental Biology 284 (2005) 479–498 481KO alleles (Zhang et al., 2001), heterozygous Cx43a1 KO
mice were interbred with the SM22a/LacZ KO mice (also
maintained in a C57BL6/J background). These double
heterozygous KO mice were then intercrossed to obtain
Cx43a1 KO mouse embryos carrying the SM22a+/LacZ
KO allele. Genotyping of the mice and embryos was carried
out using standard protocols (Huang et al., 1998a; Reaume
et al., 1995).
RNA extraction and microarray analysis
RNA was extracted either from embryonic day 17.5
(E17.5) whole ventricles (after the great vessels and atrial
appendages were removed) or after microdissection of the
ventricles into two parts, one comprising the infundibulum
that included the pouch malformation, and a second portion
comprising the remainder of the ventricle, which we refer to
as myocardium. RNA was prepared using the Qiagen
RNeasy Mini Kit, including the DNase Set module (Qiagen,
Valencia, CA). RNA integrity was examined using the
Agilent 2100 Bioanalyzer and quantified using standard 260/
280 ratios. Microarray targets were prepared using the Low
RNA Input Fluorescent Linear Amplification Kit starting
with 500 ng total RNA (Agilent Technologies). Cy3 or Cy5-
labeled target was hybridized to the 22K Agilent G4120A
Mouse Development Microarrays using the Agilent In-Situ
Hybridization Kit. The arrays were scanned using Agilent’s
Dual-Laser Microarray Scanner, with the images quantified
using Agilent Feature Extraction Software (version A.6.1.1).
Analysis included local background subtraction and LOW-
ESS dye normalization. Eighteen separate DNA microarrays
were analyzed, consisting of 3 dye swap pairs of each tissue
type (experimental/control; see Table 1). Replicate arrays for
each experimental condition were then combined by adjust-
ing the dye swap polarity and performing an error-weightedTable 1
Summary of microarray experiments
Ventricle Myocardium Infundibulum
WT KO WT KO WT KO
Hearts 6 9 9 9 12 12
RNA pools 2 3 3 3 3 3
No. arrays/poola 2 2 2 2 2 2
Total arraysb 6 6 6
Changed genes
( P < 0.01)
121 140 1275
Changed genes
(annotated)
75 64 867
>1.25-fold 56 46 774
>1.5-fold 17 22 318
a Each RNA pool was hybridized to 2 arrays, except for whole ventricle
WT. In this case, one pool was hybridized to 2 arrays, and the second pool
was hybridized to 4 arrays. Each array hybridization included 1 WT and 1
KO pool.
b The six arrays for each tissue type were hybridized as three dye swap
pairs.average of log ratios. The resulting signature genes were
filtered on P value. Statistical analysis as well as agglom-
erative hierarchical clustering was done using the Rosetta
Resolver SystemR. Genes were sorted and assigned to
functional groups using a combination of data mining and
the Genespring (Silicon Genetics) and EASE (Expression
Analysis Systematic Explorer) software packages (www.
david.niaid.nih.gov/David/upload.asp).
Real-time PCR analysis
Real-time PCR amplification of RNAwas performed in a
LightCycler thermal cycler (Roche) using the LightCycler-
RNA Master SYBR Green Kit (Roche). Gene-specific
primers were designed using MacVector software and
blasted against the NCBI database to confirm specificity
or were ordered commercially (SuperArray Bioscience
Corp., Frederick, MD). Each assay included a dilution
series and tested three independent RNA samples from each
genotype and tissue type. Amplification specificity was
monitored using melting curve analysis. Normalization to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
expression level was used to control for input RNA
concentrations. LightCycler software (Roche) was used to
calculate the crossing point, slope, and efficiency of each
dilution series. The relative change in gene expression was
recorded as the ratio of normalized target concentrations
averaged from three assays. P values were calculated using
ANOVA.
X-gal staining of mouse embryos
Hearts from developmentally staged embryos (E14.5,
E17.5, E18.5) were fixed in 2% paraformaldehyde followed
by PBS washes. Hearts were incubated in X-gal solution,
washed, and post-fixed in 10% formalin for 6–8 h as
previously described (Lo et al., 1997).
TUNEL analysis
Hearts were fixed in 4% paraformaldehyde/PBS at 4-C
overnight then transferred into 4:1 methanol:DMSO and
incubated at 4-C overnight. TUNEL with Dead-End
(Promega) colorimetric detection system was used with
minor modifications entailing blocking with 2% nonfat dry
milk and permeabilization with 0.5% Triton X-100. For
analysis of sections, hearts were fixed in 4% paraformalde-
hyde/PBS at 4-C overnight followed by embedding in
paraffin according to standard procedures. 5–10 Am
sections were processed for TUNEL analysis using the
ApopTag kit (Intergen).
Immunohistochemistry and EFIC imaging
For whole mount PECAM and VEGF staining, hearts
were processed as described (Alavizadeh et al., 2001) and
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VEGF antibody (Santa Cruz, Inc.) diluted 1:50 in blocking
solution followed by incubation in blocking solution plus
HRP-conjugated secondary antibody diluted 1:1000 (Santa
Cruz, Inc.). For immunohistochemistry of sections, hearts
were fixed in 4% paraformaldehyde/PBS at 4-C overnight
followed by paraffin embedding. Sections (5–7 Am) were
incubated with primary antibodies diluted as follows: MF20,
1:10 (Developmental Studies Hybridoma Bank, University
of Iowa), collagen VIII, 1:500 (COSMO BIO Co.), von
Willebrand Factor ab6994, 1:800 (Abcam, Inc.), VEGF,
1:50 (Santa Cruz, Inc.).
Some near term or newborn mouse fetuses were fixed in
10% formalin, processed for paraffin embedding, and
sectioned using previously described methods adapted for
episcopic fluorescence image capture (EFIC) (Rosenthal et
al., 2004; Weninger and Mohun, 2002). The image stacks
generated were 3D-reconstructed using Volocity software
(Improvision, Ltd.).Fig. 1. Agglomerative hierarchical cluster analysis of microarray data. Two
color microarray hybridizations were used to examine gene expression
changes in the Cx43a1 KO mouse heart. Hierarchical clustering was carried
out to examine expression changes in 18 microarrays comprising of 9 dye
swap pairs (x axis) based on 336 transcripts with filtering set >1.3-fold
change, P < 0.001 ( y axis). Each column represents results obtained from
one dye swap pair, with green corresponding to downregulated and red to
upregulated genes. This cluster analysis indicated that the infundibular
tissue samples had the highest-level gene expression changes. It also
revealed similar expression changes in all infundibular tissue samples,
which are markedly different from those in the myocardial and ventricular
tissues.Results
To ascertain gene expression changes in the pouch
malformations in the Cx43a1 KO mouse heart, microarray
analysis was carried out using the Agilent Mouse Develop-
ment Microarrays containing greater than 20,000 unique
oligonucleotide probes derived from the National Institute
on Aging 15K and 7.4K cDNA clone sets. They included
transcripts from pre- and early post-implantation mouse
embryos, stem cell lines, and newborn organs (Kargul et al.,
2001; Tanaka et al., 2000; VanBuren et al., 2002). We
focused our analysis on E17.5 hearts, as the pouch
malformations are well developed and contain sufficient
RNA for robust microarray analysis. For these studies, RNA
was obtained from either whole ventricles or from ventricles
further microdissected into two parts, one encompassing the
infundibular pouches and the other the remaining non-pouch
ventricle, referred to as myocardium. In parallel, RNA was
obtained from wildtype littermates—again either from
whole ventricles or from ventricles microdissected into the
infundibulum (encompassing the base of the pulmonary
outflow) and the remaining ventricular myocardium.
To control for biological variability, 2–3 separate RNA
pools were generated, with each pool comprised of RNA
from 6–12 wildtype or KO hearts (Table 1). Each pooled
sample was amplified, fluorescently labeled with Cy3 or
Cy5, and then hybridized pair-wise (KO-wildtype) as Cy3/
Cy5 and Cy5/Cy3 dye swap pairs. Dye swap hybridizations
were performed to improve ratio precision and to account
for nonreciprocal dye effects. To control for technical
variability, the targets generated with each RNA pool were
hybridized to two or four microarrays (Table 1). As a result,
a total of 18 microarrays were processed to examine gene
expression changes in the Cx43a1 KO mouse heart.
Agglomerative hierarchical cluster analysis combining all18 microarrays consisting of 9 KO-wildtype target pairs
showed good experimental consistency. The cluster analysis
showed significant gene expression changes in the infun-
dibular samples, while many fewer changes were observed
in the myocardial or whole ventricle samples (Fig. 1).
Filtering of the microarray data using a cut-off P value <
0.001 generated a list of 1275 genes that were up- or
D.L. Walker et al. / Developmental Biology 284 (2005) 479–498 483downregulated in the KO versus wildtype infundibulum of
the E17.5 Cx43a1 knockout mice. In contrast, many fewer
gene expression changes were detected in the ventricular
myocardium (140) or whole ventricle (121) (Table 1). The
significantly larger number of genes differentially expressed
in the infundibulum is consistent with the fact that this
region is the most profoundly affected by Cx43a1
deficiency.
To evaluate the reliability of the microarray data, the
transcripts for 9 genes identified as being significantly up-
or downregulated in the microarray analysis were further
quantitatively assessed using real-time PCR (Table 2). This
included Cnn1 (calponin), Casq1 (calsequestrin), Crp1
(cysteine-rich protein 1), Crp2 (cysteine and glycine-rich
protein 2), SM22a (transgelin), Thbs1 (thrombospondin),
Bok1 (Bcl2-related ovarian killer), Dll1 (delta-like 1), and
VegfA (vascular endothelial growth factor). In all instances,
the real-time PCR analysis showed excellent concordance
with the gene expression levels indicated by the microarray
analysis (Table 2). For two genes, Thbs1 and SM22a, the
microarray data showed lower fold changes than the real-
time PCR analysis, possibly reflecting lower detection
sensitivity of the microarray probes for these genes.
Gene expression changes indicate expansion of VSM,
myofibroblast, and endothelial cells
Among the numerous gene expression changes detected
in the infundibular pouch tissue, we found that many genes
typically expressed by VSM, myofibroblasts, and endothe-
lial cells were upregulated (Fig. 2). For example, upregulated
were the VSM-specific markers, SM22a, calponin, caldes-
mon, Crp1, Crp2, fibulin 2, various smooth muscle actin
isoforms (ACTG2, ACTA2), and the synthetic smooth muscle
marker, keratin 18 (KRT1–18) (Fig. 2). S100A6, a calcium
binding protein known to regulate VSM cell migration and
proliferation, was also elevated in the pouch tissue (Man-
dinova et al., 1998; Marenholz et al., 2004). Surprisingly, we
also found upregulation of the endothelial-specific markers
PECAM-1, endothelin receptor, and endothelin-converting
enzyme, as well as many genes normally highly expressedTable 2
Analysis of gene expression changes
Genes Infundibulum
Microarray Real-time PCR
Fold change P value Fold change P value
Cnn1 2.55 1.41E-25 2.33 1.90E-03
Casq1 2.57 2.60E-09 2.85 <0.0001
Crp1 2.59 3.41E-39 2.2 3.30E-03
Crp2 1.55 2.27E-04 1.99 <0.0001
Dll1 2.51 1.56E-06 2.4 1.40E-03
SM22a 1.7 1.78E-07 3.77 2.00E-04
Thbs1 3.38 9.23E-34 8.46 6.00E-04
Bok 2.09 1.42E-15 2.98 <0.0001
VegfA 1.88 1.06E-03 2.30 3.12E-02in endothelial cells, such as tenascin-C, thrombospondin,
ColIV, and stromal cell-derived factor 4 (Fig. 2). Collagen
VIII, which is expressed by both VSM and endothelial cells,
was also significantly increased (Plenz et al., 2003; Sage et
al., 1980, 1984). In addition, many fibroblast/myofibroblast
markers were elevated, including transcripts for PDGFC, a
potent mitogen for cardiac fibroblasts (Li et al., 2000;
Ponten et al., 2003), PDGFRB, and various components of
the TGFh cell-signaling pathways. The latter have been
shown to facilitate myofibroblast conversion by upregulat-
ing smooth muscle actin (SMA) (Darby et al., 1990; Eghbali
et al., 1991) and profibrotic factors such as procollagen,
fibronectin ( fn), connective tissue growth factor (ctgf ), and
tenascin-C, all of which were also upregulated in the
infundibular pouch (Fig. 2). Our microarray analysis also
indicated expression of genes encoding matrix modifying
enzymes and ECM-associated proteins expressed by myofi-
broblasts, such as the small leucine-rich proteoglycans
decorin, lumican, fibromodulin, and biglycan, as well as
chondroitin sulfate proteoglycan (Fig. 2). Overall, these
gene expression changes strongly suggest that the infun-
dibular pouch may contain ectopic endothelial, VSM, and
myofibroblast cells. These three cell types are all derived
from the epicardium and together they play an essential role
in development of the coronary vasculature (Dettman et al.,
1998; Gittenberger-de Groot et al., 1998; Mikawa and
Gourdie, 1996; Perez-Pomares et al., 1998; Poelmann et al.,
1993).
Gene expression changes suggest abnormal coronary
vascular development
Our microarray analysis also showed altered expression
of many genes in cell-signaling pathways known to regulate
vasculogenesis (Fig. 3). Thus, VEGFA, known to stimulate
and modulate vasculogenesis/angiogenesis, was elevated
(Carmeliet et al., 1996; Ferrara, 2001; Ferrara and Bunting,
1996), as were various components of the Notch signaling
pathways known to regulate various aspects of vascular
development. For example, the Notch ligands Dll-1,
expressed by arterial endothelial cells (Chi et al., 2003),
and jagged-1, expressed by both endothelial and VSM cells
(reviewed in Iso et al., 2003), are both upregulated in the
pouch (Fig. 3). Jagged-1, when overexpressed in HUVECs,
has been shown to stimulate the formation of circular
structures that resemble nascent endothelial tubes (Uytten-
daele et al., 2000; Zimrin et al., 1996). Hesr3, Robo1, and
HDAC (histone deacetylase), downstream targets of
Notch4, were also upregulated in the pouch tissue, while
Hesr1and Hesr2, also known as CHF1 or gridlock, were
downregulated. In zebrafish embryos, the graded reduction
of gridlock expression caused the expansion of veins at the
expense of arteries (Zhong et al., 2001). We also found
increased expression of EphB2 and EphB3. The Eph/ephrin
cell-signaling pathways have been shown to play an
important role in the specification of arteries versus veins
Fig. 2. Gene expression changes indicate an increase in vascular smooth muscle, endothelial, and myofibroblast cells. Selected genes found to be differentially
expressed based on microarray analysis were grouped into discrete categories. Bars represent fold change in transcript abundance, with genes that are listed in
multiple categories marked with an asterisk. Note the upregulation of genes associated with increased expression of VSM, endothelial, and myofibroblast cells
and the downregulation of cardiac muscle genes. Significant changes were also seen in multiple genes associated with the regulation of vasculogenesis/
angiogenesis. See Appendix for list of abbreviations.
D.L. Walker et al. / Developmental Biology 284 (2005) 479–498484(Adams, 2003), and studies using the EphB2/B3 double KO
mice indicate an essential role for Eph-mediated signaling in
outflow tract development (Adams et al., 1999).
The microarray analysis further showed gene expression
changes indicative of altered TGFh signaling that would
suggest abnormal vascular development. Thus, expression
of endoglin together with TGFb2 and TGFb3 was elevated.
These growth factors in concert play an important role in
VSM development (Arthur et al., 2000; Li et al., 1999;Molin et al., 2003). We also found significant down-
regulation of elk3, together with the two-fold upregulation
of egr-1. Elk3 is a transcription factor involved in vasculo-
genesis, which when deleted in KO mice causes vascular
defects associated with the upregulation of egr-1, an
immediate early gene implicated in vascular disease (Ayadi
et al., 2001a,b; Zheng et al., 2003). Also elevated were
BMP7, important for maintenance of the VSM phenotype,
and Smad5 (Vukicevic et al., 1998), a downstream effector
Fig. 3. Gene expression changes associated with the TGFh, VEGF/Notch/Ephrin-Eph, and hypoxia-related signaling pathways. Gene expression changes seen in the microarray analysis of the infundibular pouch
tissue suggest perturbations associated with specific cell-signaling pathways. Genes up- or downregulated are shown as red or green in the diagram above, with black denoting genes on the array that showed no
change in expression level. (A) Genes in the TGFh cell-signaling pathway, which play important roles in differentiation of VSM and myofibroblasts as well as angiogenesis, were shown to be up- or
downregulated. (B) A number of genes in the VEGF, Notch, and Ephrin-Eph cell-signaling pathways were up- or downregulated. These cell-signaling pathways play an important role in vasculogenesis and
angiogenesis. (C) HIF-3a is downregulated, which negatively regulates HIF during hypoxic conditions, thus allowing HIF-1a binding with CBP/p300 (Pugh and Ratcliffe, 2003). Also downregulated was cited4,
which normally competes with HIF-1a for binding with CBP/p300 (Bhattacharya and Ratcliffe, 2003). Thus, downregulation of these two genes should enhance HIF-1a binding with CBP/p300, promoting
hypoxia-induced transcription. Consistent with this, many hypoxia-responsive genes were elevated. See Appendix for list of abbreviations.
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VSM cell expansion (Chang et al., 1999). In addition, we
found increased expression of many genes in the TGFh cell-
signaling pathway known to stimulate expression of VSM
cell-specific markers (Hautmann et al., 1997) (Fig. 3).
Notable was the down- vs. upregulated expression of the
transcriptional regulators Kruppel-like factors 4 and 5
(KLF4, KLF5). This is consistent with their respective roles
in the down- vs. upregulation of transcription in VSM cells
in response to TGFh stimulation (Adam et al., 2000; King
et al., 2003) (Fig. 3). Overall, these findings suggest that
dysregulated vasculogenesis may play a central role in the
elaboration of the infundibular pouches in the Cx43a1 KO
mouse heart.
Ectopic smooth muscle cells in the pouch tissues
To investigate the distribution of VSM cells in the
Cx43a1 KO mouse, we used a lacZ-expressing SM22a
KO allele to track VSM cells in the heart (Li et al., 1996;
Xu et al., 2003; Zhang et al., 2001). This SM22a-lacZ KO
allele is homozygote viable and gives no apparent
phenotype (Zhang et al., 2001). Cx43a1 KO mouse
embryos carrying the SM22a-lacZ KO allele were
harvested at E17.5/E18.5 and X-gal stained to visualize
the distribution of VSM cells in the heart. In the Cx43a1
KO mouse, heavy lacZ expression was observed through-
out the infundibular pouch (Fig. 4I). Histological analysis
revealed a patchy and disorganized distribution of lacZ-
positive cells clustered around the sinus-like invaginations
of the infundibular pouch (Figs. 4K, M, N). As expected,
these ectopic lacZ-positive cells did not express the
cardiomyocyte marker MF20 (Figs. 4L, O). In wildtype
and heterozygous KO hearts, lacZ expression was con-
fined to the smooth muscle tunics of the great vessels,
coronary arteries, and veins (Figs. 4G, H, J). In the near
term (E17.5/18.5) KO mouse hearts, we also observed
ectopic VSM cells that appeared to be forming ventricular
pouches in other regions of the right ventricle (RV) (Figs.
5A–C, see region denoted by white asterisks). Like the
infundibular pouches, these regions exhibited a thin
compact myocardium, and abnormal trabeculation com-
prised of sinusoidal passages lined with SM22a-lacZ-
positive cells (Figs. 5D–G). In regions adjoining these
ventricular pouches, the ventricles were often lined with a
subendocardial layer of lacZ expressing cells (Figs. 5J, L).Fig. 4. SM22a-lacZ reporter gene expression shows ectopic VSM cells in the infu
reporter gene expression showed distribution of VSM cells in E14.5 wildtype (+/+
Intense lacZ expression is associated with the great vessels (P, Ao; see regions dem
the infundibulum. Histological sections (D–F) confirmed ectopic lacZ expression
ectopic VSM cells. (G–O) SM22a-lacZ expression in E17.5 wildtype (+/+), het
expression is associated with the great vessels and the coronary arteries, and i
infundibular pouch. Histological sections (J, K) showed lacZ expression associate
also abundant lacZ expression dispersed throughout the infundibular pouch, part
region in panel (M) is further magnified in panel (N). MF20 antibody immunostain
expression, which delineates presumptive VSM cells (arrows in panels L, O).These cells do not express the myocyte marker MF20
(Figs. 5K, M). In contrast, in wildtype hearts, LacZ
expressing cells were never observed in the ventricular
myocardium (Figs. 5H, I). Interestingly, the coronary
arteries and veins typically reflexed towards the infundib-
ular and ventricular pouches (Figs. 5A-C and 9P-R, 10G,
H, J). Using this same lacZ marker, we also examined KO
hearts at E14.5, a developmental stage at which the
infundibular pouches are barely detectable. VSM cells
were present in increased abundance at the base of the
outflow in the homozygous KO hearts. Quantitation of the
area of lacZ staining indicated an expansion of VSM cells
in the homozygous KO hearts, while a more modest
increase was exhibited by the heterozygous KO hearts
(Figs. 4A–C; Table 3). Histological analysis showed that
lacZ expression was largely associated with the great
vessels in the wildtype and heterozygous KO hearts (Figs.
4D, E), while in the null mutants, lacZ-positive cells were
intermingled with the trabeculated myocardium at the base
of the pulmonary outflow, the region that will eventually
give rise to the pouches (see region denoted by arrows in
Fig. 4F). In these regions, the compact myocardium
appeared thin (Fig. 4, compare F to D, E). These
observations suggest that ectopic expansion of the VSM
cells may be intimately involved in the formation of the
infundibular pouches.
Ectopic endothelial cells
To investigate the presence of ectopic endothelial cells in
the infundibular pouch tissue, we used PECAM-1 antibody
to whole mount immunostain E17.5–18.5 Cx43a1 KO
hearts. As expected, PECAM-1 stained the coronary
vasculature in the Cx43a1 KO mouse heart (Figs. 6A, B).
In addition, PECAM-1-positive cells were seen lining the
sinusoidal cavities of the infundibular pouches (Figs. 6B,
C—denoted by white asterisks). Immunohistochemistry
using an antibody to von Willebrand factor, another
endothelial marker (Sehested and Hou-Jensen, 1981),
confirmed the presence of endothelial cells lining the
sinusoids of the pouches. In addition, ectopic endothelial
cells were observed scattered throughout the pouch tissue
(Fig. 6D), often distributed in a disorganized manner in
close proximity to SM22a-lacZ-positive VSM cells. Colla-
gen VIII, which is expressed by both VSM cells and
endothelial cells and shown to be upregulated in thendibular pouch of the Cx43a1 knockout mouse heart. (A–F) SM22a-lacZ
), heterozygous (+/), and homozygous (/) Cx43a1 KO hearts (A–C)
arcated by white outline), and in the / heart, this extends abnormally into
in the infundibulum of the / heart (arrows, F), indicating the presence o
erozygous (+/), and homozygous (/) Cx43a1 KO hearts (G– I). LacZ
n addition, the Cx43a1 KO hearts show ectopic lacZ expression in the
d with the great vessels and coronary arteries. In the / heart, there was
icularly prominent along the wall of the pouch lumen (M, N). The boxed
ing (L) showed no MF20-expressing myocytes associated with SM22a-lacZ.
f
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try to be expressed at high levels in the infundibular pouch
(Fig. 6E). Also in agreement with the microarray data,
whole mount immunostaining of the E17.5 fetal mouse
heart revealed elevated VEGF expression in the epicar-dium (Figs. 7A–C). VEGF, which is proposed to drive
coronary vasculogenesis, is normally found in the epicar-
dium/subepicardial region of the fetal mouse heart (Tom-
anek et al., 1999). In the KO mouse heart, increased
epicardial VEGF expression was associated with an
Fig. 5. Ectopic SM22a-lacZ expressing cells associated with other regions of the RV. (A–C) X-gal staining of an E18.5 heart from a Cx43a1 knockout mouse
carrying the SM22a-lacZ transgene revealed lacZ-expressing VSM cells in the LCA and RCA, the coronary vein (cv), and the infundibular pouch. LacZ-
expressing cells also are seen lining the RV lumen and in an ectopic patch (white asterisk) on the lateral surface of the RV wall. Arrows delineate coronary
vessels reflexing towards lacZ-expressing cells in the pouch and RV lumen or surface. (D–G) Histological sections obtained in cross-section show lacZ-
expressing cells associated with abnormal pouch-like cavities forming in the RV chamber of a Cx43a1 KO mouse heart (for example, see regions denoted by
asterisks). These show abnormal sinusoidal folds similar to those seen in the infundibular pouches. Note that these regions also show thinning or absence of the
compact myocardium (see regions denoted by arrowheads). The cavities and trabeculation in these regions are lined with lacZ-positive cells. (H, I) Sections of
wildtype hearts through comparable regions show lacZ expression associated with the VSM cells in the outflow tract and in the coronary arteries, but otherwise
no lacZ labeling was seen in the ventricles. (J–M) High magnification views show that the SM22a-lacZ expressing cells in the Cx43a1 KO hearts are situated
in the subendocardial layer (black arrows in panels J and L). MF20 immunostaining (K, M) of the same sections showed no overlap with the lacZ expressing
cells.
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Table 3
Relative area of SM22a-lacZ expression at the base of the outflowsa
Cx43a1 genotype nb Mean SD P valuec
+/+ 5 1126 63 NA
+/ 9 1224 94 0.06121
/ 4 1498 88 0.00015
a Area of lacZ expression associated with the great vessels measured
using images of the heart captured from top down views.
b Number E14.5 Cx43a1 KO/Sm22a-lacZ hearts measured.
c t test comparison against +/+.
D.L. Walker et al. / Developmental Biology 284 (2005) 479–498 489unusual, ‘‘beaded,’’ or rounded-up cell morphology when
viewed in cross-section, which contrasts with the typical
flattened squamous epithelial cell morphology of the normalFig. 6. Ectopic expression of endothelial cell-specific markers. (A–C) Whole mou
wildtype (A) and homozygous Cx43a1 KO (B, C) hearts. The KO heart is show
otherwise is blocked by the large pouch malformation. A rotated view of the same
pouch cavities (white asterisks in panel C). (D) Immunostaining with von Willebra
together with SM22a-lacZ expressing VSM cells in the pouch tissue of the Cx43
with cells positive for von Willebrand factor. (E, F) Immunostaining with an antibo
VSM cells. Note strong expression in the epicardium and cells lining the sinusoids
was detected in the wildtype heart (F). ca = coronary artery, PA = pulmonary artepicardium (Figs. 7D, F vs. E, G). The regions of elevated
VEGF expression were situated mainly along the right and
left lateral surfaces of the heart, encompassing regions
through which the left and right coronary arteries typically
deploy (Fig. 7B). Examination of newborn Cx43a1 KO
mouse hearts by episcopic fluorescence image capture, a
method of imaging that allows for rapid 3D reconstructions
(Rosenthal et al., 2004; Weninger and Mohun, 2002),
revealed a profusion of enlarged subepicardial coronary
vascular plexuses along the left and right lateral surfaces of
the heart (Figs. 8A–E). This can be seen both in 2D sections
(Figs. 8B, C, E) and in 3D-reconstructed views of the
Cx43a1 KO heart (Figs. 8A, D).nt PECAM antibody staining delineated coronary arteries (ca) in the E17.5
n in a top down view (B) to allow viewing of the coronary artery, which
KO heart (C) shows strong PECAM staining associated with cells lining the
nd factor antibody (brown) showed the ectopic presence of endothelial cells
a1 KO mouse heart. Note the close juxtaposition of lacZ-expressing cells
dy to collagen VIII, a matrix protein typically expressed by endothelial and
of the pouch in the homozygous Cx43a1 KO heart (E), while no expression
ery, Ao = aorta, a = atria appendage attachment sites.
Fig. 7. Elevated VEGF expression in the Cx43a1 knockout mouse heart. (A–C) Whole mount VEGF antibody staining revealed strong VEGF expression in
the Cx43a1 KO heart (B, C), while only low levels of staining were observed in the wildtype heart (A). A top down view of the KO heart (C) shows that the
regions of strong VEGF expression are raised from the surface (arrowheads in panel C). (D–G) Bright field (D, E) and phase contrast images (F, G) of sections
from a Cx43a1wildtype (D, F) and KO (E, G) heart after VEGF immunostaining. VEGF expression, observed most prominently in the epicardium (ep), is
elevated in the Cx43a1 KO mouse heart. Note that the epicardium in the wildtype heart exhibits a squamous epithelial morphology (D, F), but in the knockout
heart, the epicardium, as seen in cross-sectional view, shows an abnormal rounded-up cell morphology (E, G).
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Given the finding of ectopic VSM cells and endothelial
cells together with gene expression changes indicative of
dysregulated coronary vasculogenesis/angiogenesis, we
further investigated the patterning of coronary arteries and
veins. We previously showed anomalous insertion of the
coronary artery stems into the aorta in the Cx43a1 KO
mouse heart (Li et al., 2002). Using the SM22a-lacZ
marker, we examined the distal branching pattern of the left
and right coronary arteries in the KO mouse heart. In the
wildtype heart, the main right and left coronary arteries
typically branch distally towards the apex of the heart (Figs.
9A–F), while the left and right coronary veins project
anteriorly to the front of the heart from the posterior
coronary sinus (see arrowheads in Figs. 9A–F). In contrast
to the wildtype hearts, homozygous KO hearts showed a
reduction in the branching complexity of the LCA, with the
lateral branches also showing a reduction in length (Figs.
9A–C, G–I, M–O). Branches of the RCA also were
typically reduced in length, never reaching the apex of the
heart (Figs. 9D–F, J–L, P–R). They often showedanomalous variation in gauge, alternately widening and
constricting along their length (Figs. 9P–R). The coronary
veins appeared to be enlarged, with the right coronary vein
typically reflexing towards the infundibular pouch (Figs.
9P–R; compare Figs. 9D–F). Interestingly, the LCA and
RCA usually projected lateral branches that extended to the
infundibular and ventricular pouches and adjacent regions
of the RV (Figs. 5B, C and 10G, H, J). Most heterozygous
KO hearts (8/10) had a wildtype coronary artery branching
pattern (Figs. 9G–L), while 2 exhibited reduced branching
complexity similar to that of the homozygous KO mouse
hearts. These observations indicate altered remodeling of the
coronary vessels in the Cx43a1 KO mouse heart.
Increased apoptotic cell death
While our microarray analysis showed the upregulation of
many VSM and endothelial markers, expression of many
cardiomyocyte-specific genes was downregulated, for exam-
ple calsequestrin 2, Troponins I/C/T2, SERCA2, muscle PFK,
utrophin, and aB-crystallin (Fig. 2). GATA6, a transcription
factor required for the expression of many myocardial-
Fig. 8. Abnormal subepicardial coronary plexuses in the newborn Cx43a1 knockout mouse heart. A newborn Cx43a1 knockout mouse was embedded and
sectioned, with images of the block face obtained by episcopic fluorescence image capture (EFIC). Shown here are selected 2D- and 3D-reconstructed images
of the heart. (A) 3D-reconstructed view of the heart shows an abundance of subepicardial coronary plexuses along the lateral surfaces of the heart (white
arrowheads). (B, C) Frontal (B) and transverse (C) 2D images show abnormal subepicardial coronary plexuses along the right and left lateral surfaces (white
arrowheads), but not the anterior surface of the heart (black arrow in panel C). (D, E) 3D (D)- and 2D (E)-reconstructed views of the heart along a sagittal plane
show an abnormal outpouching associated with the apex of the right ventricle (asterisk). In contrast to the abnormal subepicardial coronary plexuses seen along
the lateral surfaces of the heart (A–C), no subepicardial coronary plexuses were found along the anterior surface of the heart (white arrow). Ao: aorta, L: lung,
LV: left ventricle, p: infundibular pouch, PA: pulmonary artery, RV: right ventricle, T: thymus, V: vertebrae.
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regulated, as were many genes associated with mitochon-
drial respiration such as cytochrome c oxidase, cytochrome
b, Cox2, NADH dehydrogenase, and others. In addition,
the expression of many apoptotic genes was altered,
including Bok, Bax, Nix, Dapk1, Pdcd10, Casp9, Diablo,
Bcl2-Rambo, Bid, Casp6, Dad1, and others. Together,
these findings suggest that the ectopic expansion of the
endothelial cells, VSM, and myofibroblasts in the infun-
dibulum may be accompanied by the loss of cardiomyo-
cytes. Indeed, whole mount TUNEL labeling of E17.5–
E18.5 hearts revealed increased apoptosis associated with
the pouch tissues. TUNEL-positive foci were observed in
the infundibular (Figs. 10A–D) and ventricular pouches
(Figs. 10G–J). This was also seen with TUNEL labeling
of tissue sections spanning the sinusoidal pouch malfor-
mations. These TUNEL-positive foci were not SM22a-
lacZ-positive, indicating that apoptosis was not associated
with the VSM cells (Figs. 10E, F). Similar analysis of KO
hearts at E14.5 showed no change in TUNEL labeling,
suggesting that increased apoptotic cell death may occurpredominantly in conjunction with expansion of the
infundibular pouches during late fetal development (data
not shown).Discussion
Our microarray analysis of the E17.5 Cx43a1 knockout
mouse heart revealed upregulated expression of many genes
known to have a role in the differentiation and function of
three distinct cell types—VSMC, endothelial cells, and
myofibroblasts. In addition, the expression of many genes
associated with cell-signaling pathways important for the
regulation of vasculogenesis and angiogenesis was altered,
including VEGF and genes in the TGFh and Notch/Eph
cell-signaling pathways. These gene expression changes
were observed in the pouch tissue only. Consistent with this,
immunohistology and analysis of SM22a-lacZ reporter
expression showed ectopic VSM and endothelial cells
predominantly in the pouch tissue. The SM22a-lacZ
expressing VSM cells were usually found in close proximity
Fig. 9. Altered patterning of coronary arteries and veins in the Cx43a1 knockout heart. The left and right coronary arteries (LCA, RCA; denoted by arrows) are
delineated using SM22a-lacZ expression in three wildtype (A–F), three heterozygous (G–L), and three homozygous E18.5 Cx43a1 KO (M–R) hearts. In the
null mutant hearts (/), the LCA shows a reduction in branching complexity (compare white vs. black arrows in panels M–O vs. A–C/G–I), while the RCA
does not extend as far towards the apex (compare white vs. black arrow in panels P–R vs. D–F/J–L). In addition, the right coronary vein (RCV; denoted by
arrowheads) in the/ heart shows abnormal projection anteriorly, encircling the infundibular pouch (compare white arrowheads in panels P–R vs. D–F/J–L),
while in the +/+ and +/ hearts, the RCV extends towards the apex of the heart (black arrowheads in panels D–F/J–L).
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muscle markers, such as SM22a,SM-actin, calponin, and
CRP2 are transiently expressed in the embryonic myocar-
dium (Li et al., 1996; Miano et al., 1994; Ruzicka and
Schwartz, 1988), these markers become smooth muscle
restricted by ¨E13–E15. In addition, a constellation of
many other VSM markers and genes known to regulate
VSM cell differentiation and proliferation showed signifi-
cant changes in the expression level of the Cx43a1 KO
mouse heart.
Our studies also revealed a reduction in branching
complexity associated with the coronary arteries of the
Cx43a1 KO mouse heart. In the microarray analysis, we
found significant changes in the expression of Notch4,
delta-like 4, and neuropilin—genes known to modulate
vascular development. Altered expression of these genes has
been linked to branching anomalies, although their involve-
ment in branching of the coronary arteries has not been
investigated. One gene known to affect branching morpho-
genesis in coronaries, Fgf-1, was not represented in themicroarray (Fernandez et al., 2000). It should be noted that
these gene expression changes were seen only in the pouch
tissue, but not in the ventricular myocardium or whole
ventricles. This likely reflects the dilution of these tran-
scripts in the ventricle samples and limit in detection
sensitivity of the microarrays.
The hearts of near term Cx43a1 KO mouse fetuses
showed an abnormal profusion of enlarged subepicardial
coronary vessels, a phenotype reminiscent of vessel
hyperfusion caused by elevated VEGF expression (Drake
and Little, 1999). Consistent with this, we also found
elevated epicardial VEGF expression in the Cx43a1 KO
mouse heart. It should be noted that even modest
overexpression of VEGF in transgenic mice can cause
thinning of the compact myocardium, expansion of the
trabeculated myocardium, and enlarged epicardial coronary
vessels, phenotypes similar to those in the Cx43a1 KO
mouse (Miquerol et al., 2000). VEGF is known to induce
differentiation, proliferation, and migration of endothelial
cells, and this has been hypothesized to drive coronary
Fig. 10. Apoptosis indicated by TUNEL labeling. (A–D) Analysis by whole mount TUNEL labeling indicates increased apoptosis associated with the
infundibular pouches in E18.5 Cx43a1 knockout hearts (A, C), while little or no TUNEL labeling was seen in E18.5 wildtype hearts (B, D). (E, F) TUNEL
labeling of sections shows apoptotic cells in the epicardium, endocardium, and subendocardial tissue, as well as in the intervening pouch tissue of Cx43a1 KO
hearts. Note that TUNEL labeling was usually not associated with SM22a-lacZ-expressing cells. (G–J) An E18.5 Cx43a1 KO heart was first X-gal stained
(G) to delineate regions expressing SM22a-lacZ and then TUNEL-labeled (H–J) to examine apoptosis. Although strong X-gal staining largely obscured
TUNEL labeling in the infundibular pouch tissue, TUNEL labeling can be seen in distinct patches associated with other pouch forming regions of the RV. Thus,
regions denoted by the asterisks in panel (G) are shown in magnified views in panels (I) and (J) after TUNEL labeling. Note that branches of the LCA extended
through or adjacent to regions of TUNEL labeling (arrows in panels G, H, J). White arrowheads in panel (H) denote a coronary vein that projects to the
infundibular pouch.
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As these subepicardial coronary plexuses were seen only
in near term or newborn KO fetuses, they may be
secondary to hypoxia brought on by the coronary defi-
ciencies. Consistent with this, our microarray analysis also
showed the upregulation of many hypoxia-responsive
genes in addition to VEGF, such as phosphoglycerate
kinase, Glut1, and genes in the HIF transcription regu-
latory cascade. We also observed the downregulation of
HIF-3a and cited4, which should facilitate HIF-1a binding
to CBP/p300 and elevate hypoxia-induced transcription
(Bhattacharya and Ratcliffe, 2003) (Fig. 3C). In a recent
study, mild hypoxia in rats was shown to downregulate
HIF-3a (Heidbreder et al., 2003).
The microarray analysis also showed decreased expres-
sion of many genes encoding proteins associated with
mitochondrial respiration and myocyte contractile function,
suggesting the possibility of a reduction or loss of
cardiomyocytes in the infundibular pouch. This couldcontribute to a thinning of the compact myocardium in the
pouch forming regions. We suggest that this might be due
to apoptosis, as our microarray showed the altered
expression of many apoptotic genes and this was
associated with increased TUNEL labeling in the pouch
tissues. As the epicardium is also known to play an
important role in modulating growth and maintenance of
the underlying myocardium (Chen et al., 2002; Gitten-
berger-de Groot et al., 2000; Perez-Pomares et al., 2002;
Stuckmann et al., 2003), defects in the epicardium could
contribute to the myocardial defect in the Cx43a1 KO
mouse heart.
Origin of ectopic cells
An important question to consider is the source of the
ectopic cells in the Cx43a1 KO mouse heart. We favor their
derivation from the proepicardium/epicardium as all of the
VSMC, fibroblasts, and endothelial cells in the heart are
D.L. Walker et al. / Developmental Biology 284 (2005) 479–498494known to be epicardially derived (EPDC) (Dettman et al.,
1998; Gittenberger-de Groot et al., 1998; Manner, 1999;
Mikawa and Gourdie, 1996; Munoz-Chapuli et al., 2002;
Poelmann et al., 1993; Vrancken Peeters et al., 1999). In a
previous study, a delay in deployment of the epicardium was
shown to cause formation of pouch-like structures and
enlarged ectopic vessels in the hearts of chick embryos
(Perez-Pomares et al., 2002), a phenotype similar to that of
the Cx43a1 KO mouse. However, neural crest cells can
generate VSM cells in the proximal coronary arteries and
great vessels (Gittenberger-de Groot et al., 1999). In
addition, atrial cardiomyocytes have been suggested to
provide medial cells in the coronary vein (Vrancken Peeters
et al., 1997). We also note that the distal outflow tract has
been shown to be ensheathed by epicardial-like cells of a
different origin, but these cells are not known to generate
EPDCs (Gittenberger-de Groot et al., 2000; Manner, 1999;
Perez-Pomares et al., 2003).
We previously showed that Cx43a1-deficient proepicar-
dial cells migrate faster and have a higher rate of cell
proliferation, changes that perhaps could facilitate the
expansion of VSM and endothelial cells (Li et al., 2002).
The finding of elevated VEGFA expression in the epicar-
dium of the Cx43a1 KO mouse heart would suggest that
enhanced epicardial EMT might also increase the produc-
tion of vascular progenitors (Hallaq et al., 2004). Consistent
with this, the epicardium showed an unusual cobblestone
cell shape that suggests that it could be predisposed to EMT.
We also note that TGFb2 and 3, both of which were also
upregulated in the pouch tissue, are known to modulate
EMT in valvular morphogenesis (Boyer et al., 1999;
Camenisch et al., 2002), although some studies using chick
embryo explants indicated that, at least in vitro, these
growth factors may suppress epicardial EMT (Morabito
et al., 2001).
Epicardial and neural crest interactions
Our previous studies indicated that abnormal migration
of cardiac neural crest and proepicardial cells both
contribute to the cardiac defects in the Cx43a1 KO mouse
(Ewart et al., 1997; Huang et al., 1998a; Li et al., 2002).
Although only the proepicardium/epicardium contributes
cells to the coronary arteries, neural crest and proepicardial
cells are both required for coronary vascular development.
Neural crest cells likely provide signals that regulate
patterning and maintenance of the persisting coronary
arteries as coronary artery insertion into the aorta always
occurs adjacent to the cardiac ganglia and coronary arteries
typically deploy in parallel to the peripheral innervation in
the heart (Waldo et al., 1994). In neural crest-ablated
embryos, a spectrum of coronary artery defects is elicited
(Hood and Rosenquist, 1992; Waldo et al., 1994).
Significantly, the coronary artery defects in the crest-
ablated embryos are identical to those in the Cx43a1 KO
mouse (Li et al., 2002). Although in the Cx43a1 KOmouse the cardiac neural crest cells do reach the outflow
septum, they are reduced in numbers (Huang et al., 1998a).
In light of these findings, we propose a model in which
both deployment of vascular progenitors and development
of the coronary arteries are dependent on interactions
between the cardiac neural crest and EPDCs. In the
Cx43a1 KO mouse, an increase in proepicardial cell
motility and proliferation together with enhanced epicardial
EMT may accelerate the deployment of vascular progen-
itors in the heart. At the same time, the abundance of
neural crest cells targeted to the heart may be reduced in
the Cx43a1 mouse due to decreased neural crest cell
motility. The net effect expected is a deficiency in neural-
crest-derived signals required for the normal targeting of
the epicardially derived vascular progenitors. To examine
the validity of this model, studies are underway to
investigate whether a diffusible factor from neural crest
cells can modulate the directional movement of the
proepicardially derived cells.
Role of Cx43a1 in cell motility and EMT
Although the precise mechanism by which Cx43a1 gap
junctions regulate cell motility is not known, we pre-
viously showed that the modulation of neural crest cell
motility by Cx43a1 is not dependent on the level of gap
junction communication (Xu et al., 2001). Hence, we
hypothesized that Cx43a1 may have a signaling function
which is independent of its membrane channel and
possibly mediated by interactions with other proteins in
the cell. Cx43a1 has been shown to bind or closely
associate with a variety of cytoplasmic proteins, including
a-catenin,h-catenin, p120ctn, ZO-1, N-cadherin, and h-
tubulin (Ai et al., 2000; Barker et al., 2002; Giepmans,
2004; Giepmans and Moolenaar, 1998; Giepmans et al.,
2001; Toyofuku et al., 1998; Wei et al., 2005; Xu et al.,
2001). We recently showed that Cx43a1 is coassembled as
part of a large multiprotein complex containing cadherins
and other cadherin-associated protein and that Cx43a1
expression is a corequisite for the normal cell surface
trafficking of cadherins and other cadherin-associated
proteins (Wei et al., 2005). These findings suggest that
the loss of Cx43a1 could directly impact the regulation of
cell shape and cell–cell adhesion. This could perturb, not
only motile cell behavior, but also EMT, which together
may account for the essential role of Cx43a1 in coronary
vascular development.Acknowledgments
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Appendix A (continued)
Igf2 Insulin-like Growth Factor 2
Igfbp2 Insulin-like Growth Factor Binding Protein 2
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Actg2 Actin, gamma 2, smooth muscle, enteric
AcvR Activin Receptor
AdamTS A Disintegrin-like and Metalloproteinase
(with Thrombospondin Type 1 Motif),
1, 2, 4, 17, 24
Adm Adrenomedullin
AMHR Anti-Mullerian Hormone Receptor
ANF Atrial Natriuretic Factor
APJ Angiotensin Receptor-like 1, AGTRL1
Bgn Biglycan
Bmp Bone Morphogenetic Protein
BNP Natriuretic Peptide, Brain Type
Cald1 Caldesmon 1
Casq2 Calsequestrin 2
CBFA2T1 Core Binding Factor alpha 2,
Translocated to, 1
Cited4 CBP/P300 Interacting Transactivator with
Glu/Asp Domain 4
Cnn1 Calponin 1
Col IV, VIII Collagen IV, Collagen VIII
Crp1 Csrp1, Cysteine- and Glycine-Rich Protein 1
Crp2 Csrp2, Cysteine- and Glycine-Rich Protein 2
CryaB Crystallin, alpha-B
Csf1 Colony Stimulating Factor 1
Cspg2 Chondroitin Sulfate Proteoglycan 2
Ctgf Connective Tissue Growth Factor
Dcn Decorin
Dll1 Delta-like 1
Dll4 Delta-like 4
Ece1 Endothelin Converting Enzyme
Edg 1/5/7 Endothelial Differentiation Gene, 1, 5, and 7
Edn-RB Endothelin Receptor, Type B
Efn Ephrin
Egr1 Early Growth Response
Elk3 Ets-domain protein, Net
Eln Elastin
Emcn Endomucin
Eng Endoglin, CD105
Eph Ephrin Receptor
EpoR Erythropoietin Receptor
ErbB4 V-Erb-B2 Erythroblastic Leukemia Viral
Oncogene 4, HER4
Fbln2 Fibulin 2
Fiz1 Flt3-interacting Zinc Finger Protein 1
Flk1/KDR Kinase Insert Domain Receptor, VEGFR
Flt FMS-related Tyrosine Kinase
Fn1 Fibronectin 1
Glut1 Glucose Transporter 1
Gpc1 Glypican 1
HDAC Histone Deacetylase
Hesr1 Herp2, Hairy/Enhancer of Split Repressor
Protein, Hey1, CHF2
Hesr2 Herp1, Hairy/Enhancer of Split Repressor
Protein, Gridlock, CHF1, Hey2
Hesr3 Herp3, Hairy/Enhancer of Split Repressor
Protein, HeyL
HIF1a Hypoxia-Inducible Factor 1, alpha subunit
HIF3a Hypoxia-Inducible Factor 3, alpha subunit
HoxA9 Homeobox A9
HS6ST Heparan sulfate 6-O-sulfotransferase
Id2 Inhibitor of DNA Binding Protein 2
Jab1 Jun Activation Domain-Binding Protein
Jag1 Jagged 1
JunB Oncogene JunB
Krt18 Keratin 18, Cytokeratin 18
Krt19 Keratin 19
Lef1 Lymphoid enhancer-binding factor-1
Lox/Loxl Lysyl Oxidase, Lysyl Oxidase-Like 1
MMP14 Matrix Metalloproteinase 14
Muc Mucin 2
Mylk Myosin Light Chain Kinase, MLCK
OAZ OLF1/EBF-Associated Zinc Finger Protein
P4HA2 Prolyl 4-hydroxylase, alpha 2 subunit
Pcolce Procollagen C Endopeptidase Enhancer
Pdgf-C Platelet Derived Growth Factor C
Pdgf-RB Platelet Derived Growth Factor Receptor beta
Pecam Platelet Endothelial Cell Adhesion
Molecule, CD31
Pfkm Phosphofructokinase, Muscle
PGK Phosphoglycerate Kinase
Plod 1/2 Procollagen-lysine, 2-Oxoglutarate
5-Dioxygenase 1 and 2
Sdf1 Stromal Cell Derived Factor 1, CXCL12
Serca2 Sarcoplasmic Reticulum Ca(2+)-ATPase 2
Sm22a Transgelin, TAGLN
Sparc Osteonectin
St14 Suppressor of Tumorgenicity 1, Matriptase
STAT Signal Transducer and Activator of
Transcription
Tgfh1, 2, 3 Transforming Growth Factor Beta
TgfhR Transforming Growth Factor Beta Receptor
TGIF Transforming Growth Factor Beta-induced
Factor
Thbs1 Thrombospondin 1
Timp4 Tissue Inhibitor of Metalloproteinase 4
Tn-C Tenascin C
TnnC1 Troponin C, slow-twitch skeletal muscle
TnnI1 Troponin I, slow-twitch skeletal muscle
TnnI3 Troponin I, cardiac
TnnT2 Troponin T2, cardiac
Tpm 2/4 Tropomyosin 2 and 4
Utrn Utrophin
VDR Vitamin D Receptor
VegfA Vascular Endothelial Growth Factor A
VSM Vascular Smooth Muscle
YAP65 Yes-Associated Protein 1, 65 kDReferences
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